Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 151 (RNF151) is a predicted protein-coding gene that encodes a RING-type E3 ubiquitin ligase, characterized by a C3HC4-type RING finger domain essential for mediating protein-protein interactions and promoting ubiquitination[1][2][3][9]. It is primarily expressed in testis tissue (notably in mice, with orthologs in humans), where it localizes to the nucleus and is implicated in the later steps of spermatogenesis, particularly elongating spermatids[2][7]. RNF151 interacts with dysbindin, a protein involved in membrane biogenesis, suggesting a possible role in acrosome formation during sperm development[2]. There is currently no evidence that RNF151 is a validated therapeutic target in humans, nor are there any known drugs or established disease associations; it is not listed among standard targets for receptor, enzyme, transporter, or other classical druggable protein classes[1][3][9]. This gene is sometimes ambiguous in databases, with incomplete data for its biological or clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 151 (RNF151).